THE NEW POSSIBILITY FOR BODY REGULATION?

Researchers are rapidly investigating retatrutide, a novel medication from Eli Lilly, as a possible breakthrough in weight management. Unlike many previous approaches, retatrutide is a double -action receptor targeting both GLP-1 and GIP, chemicals that affect satiety and blood sugar balance. Ini